Pharmacological interventions for obsessive-compulsive personality disorder
dc.contributor.author | Alex, Rajesh | |
dc.contributor.author | Ferriter, Michael | |
dc.contributor.author | Jones, Hannah F. | |
dc.contributor.author | Huband, Nick | |
dc.contributor.author | Duggan, Conor | |
dc.contributor.author | Vollm, Birgit A. | |
dc.date.accessioned | 2017-09-20T15:59:33Z | |
dc.date.available | 2017-09-20T15:59:33Z | |
dc.date.issued | 2010 | |
dc.identifier.citation | Alex, R., Ferriter, M., Jones, H. F., Huband, N., Duggan, C., Vollm, B. A., Stoffers, J. & Lieb, K. (2010). Pharmacological interventions for obsessive-compulsive personality disorder. Cochrane Database of Systematic Reviews, (5), pp.1-12. | |
dc.identifier.other | 10.1002/14651858.CD008517 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12904/9597 | |
dc.description.abstract | This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the potential beneficial and adverse effects of pharmacological interventions for people with obsessive-compulsive personality disorder and to make recommendations for future areas of research.; | |
dc.description.uri | http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008517/full | |
dc.format | Full text uploaded | |
dc.subject | Drug therapy | |
dc.subject | Obsessive-compulsive disorder | |
dc.title | Pharmacological interventions for obsessive-compulsive personality disorder | |
dc.type | Article | |
refterms.dateFOA | 2021-06-14T10:51:09Z | |
html.description.abstract | This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the potential beneficial and adverse effects of pharmacological interventions for people with obsessive-compulsive personality disorder and to make recommendations for future areas of research.; |